Maternal betaine supplementation ameliorates fatty liver disease in offspring mice by inhibiting hepatic NLRP3 inflammasome activation

被引:1
|
作者
Li, Lun [1 ]
Sun, Liuqiao [2 ]
Liang, Xiaoping [3 ]
Ou, Qian [3 ]
Tan, Xuying [4 ]
Li, Fangyuan [3 ]
Lai, Zhiwei [3 ]
Ding, Chenghe [3 ]
Chen, Hangjun [3 ]
Yu, Xinxue [3 ]
Wu, Qiongmei [3 ]
Wei, Jun [5 ]
Wu, Feng [5 ]
Wang, Lijun [3 ]
机构
[1] Guangzhou Women & Childrens Med Ctr, Dept Delivery Room, Guangzhou 510623, Peoples R China
[2] Jinan Univ, Sch Med, Dept Maternal Child & Adolescent Hlth, Guangzhou 510632, Peoples R China
[3] Jinan Univ, Sch Med, Dept Nutr, 601 Huangpu Rd West, Guangzhou 510632, Peoples R China
[4] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangdong Prov Clin Res Ctr Child Hlth, Dept Child Hlth Care, Guangzhou 510623, Peoples R China
[5] Guangzhou Customs, Dept Sci & Technol, Guangzhou 510623, Peoples R China
关键词
Gestation; betaine; high-fat diet; streptozotocin; fatty liver; inflammation; HYPERHOMOCYSTEINEMIA; PROGRESSION; FIBROSIS; NAFLD;
D O I
10.4162/nrp.2023.17.6.1084
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
BACKGROUND/OBJECTIVES: Previous research has shown maternal betaine supplementation alleviates fetal-derived hepatic steatosis. Therefore, this study examined the anti-inflammatory effect of maternal betaine intake in offspring mice and its mechanism.MATERIALS/METHODS: Female C57BL/6J mice and their offspring were randomly divided into 3 groups according to the treatment received during gestation and lactation: control diet (CD), fatty liver disease (FLD), and fatty liver disease + 1% betaine (FLD-BET). The FLD group was given a high-fat diet and streptozotocin (HFD + STZ), and the FLD-BET group was treated with HFD + STZ + 1% betaine. After weaning, the offspring mice were given a normal diet for 5 weeks and then dissected to measure the relevant indexes.RESULTS: Compared to the CD group, the offspring mice in the FLD group revealed obvious hepatic steatosis and increased serum levels of alanine aminotransferase, interleukin (IL) 6, and tumor necrosis factor (TNF)-alpha; maternal betaine supplementation reversed these changes. The hepatic mRNA expression levels of IL-6, IL-18, and Caspase-1 were significantly higher in the FLD group than in the CD group. Maternal betaine supplementation reduced the expression of IL-1 beta, IL-6, IL-18, and apoptosis-associated speck-like protein containing C-terminal caspase recruitment domain (ASC). Maternal betaine supplementation also reversed the increasing protein expressions of nitric oxide dioxygenase-like receptor family pyrin domain containing 3 (NLRP3), ASC, Caspase-1, IL-1 beta, and IL-18 in offspring mice exposed to HFD + STZ. Maternal betaine supplementation decreased the homocysteine (Hcy) and s-adenosine homocysteine (SAH) levels significantly in the livers. Furthermore, the hepatic Hcy concentrations showed significant inverse relationships with the mRNA expression of TNF-alpha, NLRP3, ASC, and IL-18. The hepatic SAH concentration was inversely associated with the IL-1 beta mRNA expression.CONCLUSIONS: The lipotropic and anti-inflammatory effect of maternal betaine supplementation may be associated with the inhibition of NLRP3 inflammasome in the livers of the offspring mice.
引用
收藏
页码:1084 / 1098
页数:15
相关论文
共 50 条
  • [1] Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice
    Yu, Yongxiang
    Chen, Dongru
    Zhao, Yuhua
    Zhu, Jianjun
    Dong, Xiaohui
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2021, 35
  • [2] Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice
    Meng, Ling-Cui
    Zheng, Jia-Yi
    Qiu, Yu-Hui
    Zheng, Li
    Zheng, Jue-Yan
    Liu, Yu-Qing
    Miao, Xiao-Lu
    Lu, Xin-Yi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111
  • [3] Demethylenetetrahydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice
    Zhang, Yuanqiang
    Wen, Jing
    Liu, Dongqing
    Qiu, Zhen
    Zhu, Qianqian
    Li, Ruiyan
    Zhang, Yubin
    LIFE SCIENCES, 2021, 281
  • [4] Rhubarb free anthraquinones improved mice nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome
    Chao Wu
    Yanqin Bian
    Bingjie Lu
    Dan Wang
    Nisma Lena Bahaji Azami
    Gang Wei
    Feng Ma
    Mingyu Sun
    Journal of Translational Medicine, 20
  • [5] Rhubarb free anthraquinones improved mice nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome
    Wu, Chao
    Bian, Yanqin
    Lu, Bingjie
    Wang, Dan
    Azami, Nisma Lena Bahaji
    Wei, Gang
    Ma, Feng
    Sun, Mingyu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [6] Hypericum sampsonii ameliorates radiodermatitis by inhibiting NLRP3 inflammasome activation
    Liao, Jiayu
    Liu, Zhihong
    Wu, Sumei
    SKIN RESEARCH AND TECHNOLOGY, 2024, 30 (09)
  • [7] Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation
    Yang, Soo Jin
    Lim, Yunsook
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (05): : 693 - 701
  • [8] PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice
    Sun, Chen-Chen
    Zhang, Chen-Yu
    Duan, Jia-Xi
    Guan, Xin-Xin
    Yang, Hui-Hui
    Jiang, Hui-Ling
    Hammock, Bruce D.
    Hwang, Sung Hee
    Zhou, Yong
    Guan, Cha-Xiang
    Liu, Shao-Kun
    Zhang, Jun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 523 (04) : 1020 - 1026
  • [9] Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation
    Cao, Run
    Jing, Jing
    Ma, Yuting
    Qi, Wenqing
    Huang, Xinyu
    Zhang, Chaofang
    Lu, Zhizhuo
    He, Jiayi
    Wang, Guiling
    Ma, Yuanfang
    Zhang, Hailong
    JOURNAL OF INFLAMMATION RESEARCH, 2025, 18 : 1773 - 1786
  • [10] Bile acids ameliorates lipopolysaccharide-induced endometritis in mice by inhibiting NLRP3 inflammasome activation
    Yang, Miaoxin
    Liu, Suyuan
    Cai, Jiangxue
    Sun, Xiaoxiao
    Li, Chenxuan
    Tan, Meiling
    He, Bin
    LIFE SCIENCES, 2023, 331